Everence Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Sell |
10,250
-6,460
| -39% | -$178K | 0.02% | 605 |
|
|
2025
Q1 | $474K | Buy |
16,710
+8,770
| +110% | +$249K | 0.03% | 384 |
|
|
2024
Q4 | $330K | Sell |
7,940
-1,390
| -15% | -$57.8K | 0.02% | 533 |
|
|
2024
Q3 | $624K | Hold |
9,330
| – | – | 0.04% | 354 |
|
|
2024
Q2 | $1.03K | Hold |
9,330
| – | – | 0.07% | 221 |
|
|
2024
Q1 | $994 | Hold |
9,330
| – | – | 0.07% | 242 |
|
|
2023
Q4 | $928K | Buy |
9,330
+1,170
| +14% | +$116K | 0.07% | 248 |
|
|
2023
Q3 | $843 | Hold |
8,160
| – | – | 0.07% | 247 |
|
|
2023
Q2 | $1.04M | Hold |
8,160
| – | – | 0.08% | 201 |
|
|
2023
Q1 | $1.25K | Hold |
8,160
| – | – | 0.1% | 171 |
|
|
2022
Q4 | $1.47K | Sell |
8,160
-2,420
| -23% | -$435 | 0.13% | 157 |
|
|
2022
Q3 | $1.25M | Hold |
10,580
| – | – | 0.12% | 156 |
|
|
2022
Q2 | $1.51M | Buy |
10,580
+2,480
| +31% | +$354K | 0.13% | 137 |
|
|
2022
Q1 | $1.4M | Hold |
8,100
| – | – | 0.11% | 158 |
|
|
2021
Q4 | $2.06M | Buy |
8,100
+3,730
| +85% | +$947K | 0.15% | 119 |
|
|
2021
Q3 | $1.68M | Buy |
+4,370
| New | +$1.68M | 0.14% | 130 |
|